|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 0.8762 USD | -28.76% |
|
-11.05% | -77.00% |
| 09-24 | IMUNON, Inc. Presents Update On IMNN-001 Development Program For Women With Newly Diagnosed Advanced Ovarian Cancer | CI |
| 09-23 | Imunon, Inc. - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMUNON, INC. | Bio Therapeutic Drugs | -28.76% | -11.05% | -77.00% | -81.93% | -99.51% | 6.9M |  |  | |
- Stock Market
- Stocks
- IMNN Stock
- Charts Imunon, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
